secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2026-06-01T20:32:30+00:00
Accession:  0000105770-26-000080
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair
--------------------------------------------------------------------------------

- Michel Lagarde appointed President & CEO of West Pharmaceutical, effective Aug 31, 2026.
- Eric Green retires as President, CEO and Board Chair; Robert F. Friel becomes Board Chair.
- Employment agreement: $1,175,000 base salary; target annual incentive 125% of base; 2026 LTI grant valued at $8,611,111.
- Lagarde receives inducement equity awards up to $10M, including sign-on grant of $6,875,000 and matching RSUs/options.
- Lagarde previously served as EVP & COO at Thermo Fisher Scientific; holds BBA from European University Antwerp.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/0000105770-26-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/wst-20260531.htm
  HTML page:      https://secwatch.observer/filing/0000105770-26-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer